Top Industry Leaders in the Cell Counting Market
Latest Cell Counting Companies Update:
ACADIA Pharmaceuticals: Acquired CerSci Therapeutics Inc. in October 2023, gaining access to promising non-opioid pain medication candidates for patch delivery.
Grünenthal GmbH: Completed Phase 3 trials for Qutenza (lidocaine patch) for diabetic peripheral neuropathy, marking a potential non-opioid option for this prevalent condition.
Zogenix: Successfully tested ZX004, a novel non-opioid patch for neuropathic pain, in a Phase 2 trial, showcasing its potential for future development.
Purdue Pharma L.P.: Filed for bankruptcy in 2019 amidst the opioid crisis and ongoing lawsuits, impacting the distribution of OxyContin patches.
List of Cell Counting Key companies in the market
- Thermo Fisher Scientific (US)
- Merck KGaA (Germany)
- Danaher Corporation (US)
- Bio-Rad Laboratories, Inc. (US)
- Logos Biosystems, Inc. (South Korea)
- Olympus Corporation (Japan)
- Agilent Technologies, Inc. (US)
- PerkinElmer, Inc. (US)
- Sysmex Corporation (Japan)
- Abbott Laboratories (US)